PD
NVAX icon

Point72 (DIFC)’s Novavax NVAX Stock Holding History

Point72 (DIFC)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12K Sell
1,387
-19,928
-93% -$155K ﹤0.01% 930
2025
Q2 		$134K Buy
+21,315
New +$141K 0.01% 870

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 (DIFC)'s NVAX Position: Q3 2025 in Review

Point72 (DIFC) reduced its Novavax (NVAX) stake by 93% in Q3 2025, selling an estimated $155K and leaving 1,387 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Point72 (DIFC) first reported a position in NVAX in Q2 2025 and has held it in 2 quarters since. The position peaked at $134K in Q2 2025. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Point72 (DIFC) held 1,387 shares of Novavax worth $12K as of Q3 2025.
  • Point72 (DIFC) sold 19,928 Novavax shares in Q3 2025, an estimated $155K.
  • Novavax made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #930 holding.
  • Point72 (DIFC) first reported a position in Novavax in Q2 2025 and has held it in 2 quarters since.
  • Point72 (DIFC)'s Novavax position peaked at $134K in Q2 2025.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.